Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | VDR | P11473 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29130829 | 0.91 | HTT (0.53) | GAACA1CA2CA12CA3 | |
| SCHEMBL476786 | 0.90 | GAA (0.54) | GAACA1CA2CA12CA3 | |
| SCHEMBL12846997 | 0.88 | GAA (0.52) | GAACA1CA2CA12CA3 | |
| SCHEMBL30027753 | 0.86 | GAA (0.50) | GAACA1CA2CA12CA3 | |
| SCHEMBL12830396 | 0.86 | GAA (0.50) | GAACA1CA2CA12CA3 | |
| SCHEMBL9767634 | 0.84 | GAA (0.48) | GAACA1CA2CA12CA3 | |
| SCHEMBL6490 | 0.84 | GAA (0.59) | GAACA1CA2CA12CA3 | |
| SCHEMBL28963307 | 0.84 | GAA (0.43) | GAACA1CA2CA12CA3 | |
| SCHEMBL22105941 | 0.83 | GAA (0.46) | GAACA1CA2CA12CA3 | |
| SCHEMBL16852304 | 0.83 | TLR9 (0.47) | GAACA1CA2CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119650855-A | Electrolyte and lithium ion battery using same | 惠州亿纬锂能股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-112558416-B | Method for manufacturing semiconductor device | 台湾积体电路制造股份有限公司 | 2025-03-18 | — | — | CN | disclosed |
| US-20240299597-A1 | 3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling | UNIV EMORY (US) | 2024-09-12 | — | — | US | disclosed |
| CN-118574820-A | Method for synthesizing quinazoline compounds | 基因泰克公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-116547283-A | Substituted tricyclic compounds | 联合化学实验室有限公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-110678467-B | Therapeutic compounds and compositions and methods of use thereof | 豪夫迈·罗氏有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-110650959-B | Therapeutic compounds and compositions and methods of use thereof | 豪夫迈·罗氏有限公司 | 2023-04-18 | — | — | CN | disclosed |
| WO-2023278827-A1 | 3-IODOPROPYL-1,2,3-TRIAZOL-1-YL, 3-BROMOPROPYL-1,2,3-TRIAZOL-1-YL, AND DERIVATIVES FOR USES IN LABELING | EMORY UNIVERSITY (US) | 2023-01-05 | — | — | WO | disclosed |
| EP-3487837-B1 | PROCESS FOR THE PREPARATION OF SPIROHETEROCYCLIC PYRROLIDINE DIONE HERBICIDES BY MEANS OF THE INTERMEDIATE COMPOUND 2-(4-CHLORO-2,6-DIMETHYL-PHENYL)ACETIC ACID | SYNGENTA PARTICIPATIONS AG (CH) | 2022-08-17 | — | — | EP | disclosed |
| CN-109890829-B | Pyrazolo [1,5a ] pyrimidine derivatives as IRAK4 modulators | 豪夫迈·罗氏有限公司 | 2022-07-15 | — | — | CN | disclosed |
| US-8426102-B2 | Lithographic printing plate precursor and plate making method | FUJIFILM CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-8309294-B2 | — | — | 2012-11-13 | — | — | US | disclosed |
| US-20110127487-A1 | ELECTRONIC DEVICE FOR A RECONFIGURABLE LOGIC CIRCUIT | SONY CORPORATION (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20080318155-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLATE MAKING METHOD | FUJIFILM CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | Terpetschnig, Ewald (US) | 2007-12-06 | — | — | US | disclosed |
| CN-1227249-C | Pyrimidine compounds | ASTRAZENECA AB (SE) | 2005-11-16 | — | — | CN | disclosed |
| US-6525106-B1 | High internal phase emulsion polymerization producing flexible, microporous, open celled foams | THE PROCTER & GAMBLE COMPANY | 2003-02-25 | — | — | US | disclosed |
| CN-1349528-A | Pyrimidine compounds | ASTRAZENECA AB (SE) | 2002-05-15 | — | — | CN | disclosed |
| EP-1169374-A1 | METHOD FOR CONTINUOUS CURING OF HIPE INTO HIPE FOAMS | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-09 | — | — | EP | disclosed |
| WO-2000050498-A1 | METHOD FOR CONTINUOUS CURING OF HIPE INTO HIPE FOAMS | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299597-A1 | 3-Iodopropyl-1,2,3-Triazol-1-yl, 3-Bromopropyl-1,2,3-Triazol-1-yl, and Derivatives for Uses in Labeling | PAICS, ALG3, PAG1 | GAA 1494/4885CA1 830/4885CA2 3707/4885 |
| US-20070281363-A1 | Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence | SPR, SRRT, SQLE | GAA 2040/4885CA1 443/4885CA2 129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.